 SAN DIEGO, July 14, 2021 PRNewswire -- Evofem Biosciences, Inc., NASDAQ: EVFM today provided a preliminary look at Phexxi lactic acid, citric acid and potassium bitartrate data for the second quarter of 2021 and revealed new insights into the demographics of women who are using this hormone-free contraceptive method. More than 14,000 Phexxi units were dispensed in the second quarter of 2021. 